Phibro Animal Health (PAHC): insider & executive buying
Phibro Animal Health · Health Care · ref. ETF XLV · price $36.35
In short — 1 insider bought Phibro Animal Health over ~6 months (1 buy, total $318k, latest May 29, 26). Public Form 4 data, informative (not a performance signal).
Are Phibro Animal Health's executives buying their own shares? Here are the disclosed insider buys over the last 6 months — a transparency data point, not an outperformance signal.
📈 1-year price
$36.35-5.5% over range
Aug 28, 25low $28.52 · high $59.58Aug 27, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Hold
0% recommend buying · 1 analysts
Latest insider buys on Phibro Animal Health
| Date | Insider | Role | Shares | Amount |
|---|---|---|---|---|
| May 29, 26 | Corcoran E Thomas | Dir | 10,000 | $318k |
⚠️ Open-market buys reported to the SEC (Form 4). Transparency data, not advice nor an outperformance signal (our backtests show no reliable edge).
Frequently asked questions
Have Phibro Animal Health's executives bought shares recently?
1 Phibro Animal Health insider(s) bought $318k over ~6 months (latest May 29, 26). A buy shows confidence, but our backtests show no performance edge.
Is insider buying a good signal for PAHC?
It's useful transparency data, but NOT a performance guarantee: our historical tests show no reliable edge from following insider buys. Cross-check with fundamentals and analyst views.
Where does this data come from?
From Form 4 filings with the SEC (mandatory for officers and 10%+ holders), aggregated and refreshed regularly.
💬 A question about Phibro Animal Health? The JPI assistant answers using our backtest data.
Keep exploring Phibro Animal Health